![Heather Faulds](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heather Faulds
Corporate Officer/Principal bij
TYRA BIOSCIENCES, INC.
Profiel
Heather Faulds is Chief Regulatory Officer at Tyra Biosciences, Inc. since 2025.
Former positions include Senior Director-Regulatory Affairs at Biogen, Inc., Manager-Regulatory Affairs & CMC Operations at Oncotelic Therapeutics, Inc., Senior Vice President-Regulatory Affairs at Scholar Rock Holding Corp.
from 2017 to 2020, SVP-Regulatory Affairs & Knowledge Management at Alkermes Plc, and Chief Regulatory Affairs Officer at Fulcrum Therapeutics, Inc. Education includes graduate studies at Massachusetts College of Pharmacy & Health Science and undergraduate studies at State University of New York at Albany.
Actieve functies van Heather Faulds
| Bedrijven | Functie | Begin |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Corporate Officer/Principal | 08-12-2025 |
Eerdere bekende functies van Heather Faulds
| Bedrijven | Functie | Einde |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Algemeen Adviseur | 01-06-2020 |
| FULCRUM THERAPEUTICS, INC. | Algemeen Adviseur | - |
| ALKERMES PLC | Algemeen Adviseur | - |
| ONCOTELIC THERAPEUTICS, INC. | Algemeen Adviseur | - |
| BIOGEN INC. | Algemeen Adviseur | - |
Opleiding van Heather Faulds
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
